Impact of circulating tumor DNA mutant allele fraction on prognosis in RAS ‐mutant metastatic colorectal cancer-Reference-Cited by-同舟云学术

Impact of circulating tumor DNA mutant allele fraction on prognosis in RAS ‐mutant metastatic colorectal cancer

Published:2019-07-31 Issue:9 Volume:13 Page:1827-1835
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Mol Oncol

Author:

Elez Elena¹²,Chianese Chiara³^ORCID,Sanz‐García Enrique¹²,Martinelli Erica⁴,Noguerido Alba¹²,Mancuso Francesco Mattia³,Caratù Ginevra³,Matito Judit³,Grasselli Julieta¹⁵,Cardone Claudia⁴,Esposito Abate Riziero⁶,Martini Giulia¹²,Santos Cristina⁵,Macarulla Teresa¹²,Argilés Guillem¹²,Capdevila Jaume¹²,Garcia Ariadna¹²,Mulet Nuria¹²⁵,Maiello Evaristo⁷,Normanno Nicola⁶,Jones Frederick⁸,Tabernero Josep¹²,Ciardello Fortunato⁴,Salazar Ramon⁵,Vivancos Ana³

Affiliation:

1. Department of Medical Oncology Vall d'Hebron Institute of Oncology Barcelona Spain

2. Department of Medical Oncology Vall d' Hebron University Hospital, Universitat Autònoma de Barcelona Spain

3. Cancer Genomics Group Vall d'Hebron Institute of Oncology Barcelona Spain

4. Medical Oncology, Department of Clinical and Experimental Medicine ‘F. Magrassi' Università della Campania ‘L. Vanvitelli' Napoli Italy

5. Department of Medical Oncology, Catalan Institute of Oncology Universitat de Barcelona, L'Hospitalet Spain

6. Cell Biology and Biotherapy Unit Istituto Nazionale Tumori ‘Fondazione Giovanni Pascale' IRCCS Napoli Italy

7. Medical Oncology IRCCS Casa Sollievo della Sofferenza San Giovanni Rotondo (Foggia) Italy

8. Sysmex Inostics Mundelein IL USA

Funder

Instituto de Salud Carlos III

Federación Española de Enfermedades Raras

Associazione Italiana per la Ricerca sul Cancro

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.12547

Reference21 articles.

1. Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials

2. Nanofluidic Digital PCR and Extended Genotyping of RAS and BRAF for Improved Selection of Metastatic Colorectal Cancer Patients for Anti-EGFR Therapies

3. Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies

4. Clinical activity of FOLFIRI plus cetuximab according to extended gene mutation status by next-generation sequencing: findings from the CAPRI-GOIM trial

5. An application of changepoint methods in studying the effect of age on survival in breast cancer

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A panorama of colon cancer in the era of liquid biopsy;The Journal of Liquid Biopsy;2024-06

2. Immunotherapy: Constructive Approach for Breast Cancer Treatment;Breast Cancer: Targets and Therapy;2023-12

3. Early changes in circulating tumor DNA (ctDNA) predict treatment response in metastatic KRAS-mutated colorectal cancer (mCRC) patients;Heliyon;2023-11

4. The Clinical Significance of Circulating Tumor DNA for Minimal Residual Disease Identification in Early-Stage Non-Small Cell Lung Cancer;Life;2023-09-15

5. Tumor-Free Resection Margin Distance in the Surgical Treatment of Node-Negative Squamous Cell Cancer of the Vulva Has No Impact on Survival: Analysis of a Large Patient Cohort in a Tertiary Care Center;Cancers;2023-08-15